Lumibird SA
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical a… Read more
Lumibird SA (LBIRD) - Net Assets
Latest net assets as of June 2025: €199.81 Million EUR
Based on the latest financial reports, Lumibird SA (LBIRD) has net assets worth €199.81 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€435.94 Million) and total liabilities (€236.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €199.81 Million |
| % of Total Assets | 45.83% |
| Annual Growth Rate | 5.05% |
| 5-Year Change | 20.67% |
| 10-Year Change | 631.17% |
| Growth Volatility | 38.76 |
Lumibird SA - Net Assets Trend (2000–2024)
This chart illustrates how Lumibird SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lumibird SA (2000–2024)
The table below shows the annual net assets of Lumibird SA from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €198.01 Million | +2.43% |
| 2023-12-31 | €193.30 Million | -0.07% |
| 2022-12-31 | €193.44 Million | +6.68% |
| 2021-12-31 | €181.33 Million | +10.51% |
| 2020-12-31 | €164.08 Million | +31.32% |
| 2019-12-31 | €124.95 Million | +37.64% |
| 2018-12-31 | €90.78 Million | +21.76% |
| 2017-12-31 | €74.56 Million | +144.98% |
| 2016-12-31 | €30.43 Million | +12.38% |
| 2015-12-31 | €27.08 Million | +15.58% |
| 2014-12-31 | €23.43 Million | +22.32% |
| 2013-12-31 | €19.16 Million | +18.01% |
| 2012-12-31 | €16.23 Million | -18.67% |
| 2011-12-31 | €19.96 Million | +9.45% |
| 2010-12-31 | €18.23 Million | +8.14% |
| 2009-12-31 | €16.86 Million | -28.95% |
| 2008-12-31 | €23.73 Million | +4.30% |
| 2007-12-31 | €22.75 Million | -4.87% |
| 2006-12-31 | €23.92 Million | +7.40% |
| 2005-12-31 | €22.27 Million | +79.24% |
| 2004-12-31 | €12.43 Million | +19.45% |
| 2003-12-31 | €10.40 Million | +0.59% |
| 2002-12-31 | €10.34 Million | -5.60% |
| 2001-12-31 | €10.96 Million | -81.97% |
| 2000-12-31 | €60.76 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lumibird SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 569500000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €5.70 Million | 2.88% |
| Common Stock | €22.47 Million | 11.35% |
| Other Comprehensive Income | €91.19 Million | 46.06% |
| Other Components | €78.65 Million | 39.72% |
| Total Equity | €198.01 Million | 100.00% |
Lumibird SA Competitors by Market Cap
The table below lists competitors of Lumibird SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Changsha Tongcheng Holdings Co Ltd
SHE:000419
|
$227.08 Million |
|
American Integrity Insurance Group, Inc.
NYSE:AII
|
$227.08 Million |
|
Sesoda Corp
TW:1708
|
$227.10 Million |
|
Citic Press Corp
SHE:300788
|
$227.12 Million |
|
Odfjell B
OL:ODFB
|
$227.05 Million |
|
7C Solarparken AG
PINK:SCPKF
|
$227.05 Million |
|
Wuxi Chemical Equipment Co. Ltd. A
SHE:001332
|
$226.85 Million |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
$226.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lumibird SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 193,301,000 to 198,007,000, a change of 4,706,000 (2.4%).
- Net income of 5,695,000 contributed positively to equity growth.
- Share repurchases of 761,000 reduced equity.
- Other comprehensive income increased equity by 6,847,000.
- Other factors decreased equity by 7,075,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.70 Million | +2.88% |
| Share Repurchases | €761.00K | -0.38% |
| Other Comprehensive Income | €6.85 Million | +3.46% |
| Other Changes | €-7.08 Million | -3.57% |
| Total Change | €- | 2.43% |
Book Value vs Market Value Analysis
This analysis compares Lumibird SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.38x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.40x to 2.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | €3.34 | €21.40 | x |
| 2010-12-31 | €3.71 | €21.40 | x |
| 2011-12-31 | €4.18 | €21.40 | x |
| 2012-12-31 | €3.38 | €21.40 | x |
| 2013-12-31 | €2.46 | €21.40 | x |
| 2014-12-31 | €2.75 | €21.40 | x |
| 2015-12-31 | €3.33 | €21.40 | x |
| 2016-12-31 | €3.43 | €21.40 | x |
| 2017-12-31 | €4.71 | €21.40 | x |
| 2018-12-31 | €5.73 | €21.40 | x |
| 2019-12-31 | €7.42 | €21.40 | x |
| 2020-12-31 | €7.39 | €21.40 | x |
| 2021-12-31 | €8.08 | €21.40 | x |
| 2022-12-31 | €8.62 | €21.40 | x |
| 2023-12-31 | €8.68 | €21.40 | x |
| 2024-12-31 | €9.00 | €21.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lumibird SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.71%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 2.17x
- Recent ROE (2.88%) is above the historical average (2.47%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 6.58% | 2.28% | 0.95x | 3.04x | €-374.50K |
| 2002 | 11.70% | 3.51% | 1.08x | 3.09x | €175.90K |
| 2003 | 17.78% | 4.68% | 1.40x | 2.71x | €808.80K |
| 2005 | 12.95% | 7.81% | 0.84x | 1.97x | €657.90K |
| 2006 | 8.80% | 5.08% | 0.75x | 2.31x | €-288.00K |
| 2009 | -39.85% | -15.12% | 0.81x | 3.25x | €-8.41 Million |
| 2010 | 4.02% | 1.31% | 1.01x | 3.03x | €-1.09 Million |
| 2011 | 6.10% | 2.04% | 1.03x | 2.92x | €-777.90K |
| 2012 | -21.53% | -6.92% | 0.96x | 3.25x | €-5.12 Million |
| 2013 | -1.77% | -0.61% | 1.08x | 2.69x | €-2.25 Million |
| 2014 | -4.72% | -2.09% | 0.96x | 2.35x | €-3.45 Million |
| 2015 | 7.85% | 3.36% | 1.03x | 2.26x | €-582.10K |
| 2016 | 2.12% | 1.01% | 1.05x | 2.01x | €-2.40 Million |
| 2017 | 2.33% | 4.60% | 0.31x | 1.62x | €-5.72 Million |
| 2018 | 8.90% | 7.93% | 0.67x | 1.66x | €-1.00 Million |
| 2019 | 7.06% | 7.83% | 0.58x | 1.55x | €-3.67 Million |
| 2020 | 3.44% | 4.35% | 0.42x | 1.86x | €-10.77 Million |
| 2021 | 7.64% | 8.53% | 0.47x | 1.92x | €-4.27 Million |
| 2022 | 5.87% | 5.84% | 0.52x | 1.92x | €-7.99 Million |
| 2023 | 3.69% | 3.45% | 0.51x | 2.10x | €-12.20 Million |
| 2024 | 2.88% | 2.71% | 0.49x | 2.17x | €-14.11 Million |
Industry Comparison
This section compares Lumibird SA's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,195,809
- Average return on equity (ROE) among peers: -10.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lumibird SA (LBIRD) | €199.81 Million | 6.58% | 1.18x | $227.06 Million |
| Eurofins-Cerep SA (ALECR) | $25.16 Million | 15.33% | 0.40x | $93.20 Million |
| KLEA HOLDING (ALKLH) | $6.19 Million | -45.35% | 1.09x | $33.56 Million |
| Predilife (ALPRE) | $-764.29K | 0.00% | 0.00x | $3.26 Million |